Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 11:22 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1417–1440 of 2,913 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Event Clear all

Conditions: Skin Diseases, Keloid, Scar, Fibrosis, Hypertrophic Skin
Interventions: HF-LED-RL Phototherapy, Mock Therapy; Device
Lead sponsor: VA Northern California Health Care System; Federal
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Mather, California

Conditions: Thrombosis
Interventions: Heparin; Drug
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 1,015 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2012
U.S. locations: 4
States / cities: Rochester, Minnesota • Chapel Hill, North Carolina • Durham, North Carolina + 1 more

Conditions: Telemedicine
Interventions: Telemedicine intervention; Other
Lead sponsor: Washington University School of Medicine; Other
Eligibility: Not listed
Enrollment: 25,506 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Heavy Drinking
Interventions: Academic Episodic Future Thinking, Vivid Memory Task; Behavioral · Other
Lead sponsor: University of Memphis; Other
Eligibility: 18 Years to 25 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Dry Needling
Interventions: Nominal Group Technique - 2 to 3 hour virtual meeting; Other
Lead sponsor: Youngstown State University; Other
Eligibility: 18 Years to 100 Years
Enrollment: 5 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Youngstown, Ohio

Conditions: Healthy
Interventions: Associative Inference, Probabilistic Inference; Behavioral
Lead sponsor: University of Texas at Austin; Other
Eligibility: 13 Years to 25 Years
Enrollment: 142 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Colon Cancer, Rectal Cancer
Interventions: TAS-102, oxaliplatin, irinotecan with bevacizumab; Drug
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 9
States / cities: Elizabeth, New Jersey • Jersey City, New Jersey • Lakewood, New Jersey + 5 more

Conditions: Histiocytic Disorders
Interventions: Cobimetinib; Drug
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 16 Years and older
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2022
U.S. locations: 2
States / cities: Rochester, Minnesota • New York, New York

Conditions: Cardiovascular Diseases
Interventions: Telmisartan, Combination of Telmisartan and Ramipril, Ramipril; Drug
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 55 Years and older
Enrollment: 31,546 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2001
U.S. locations: 100
States / cities: Athens, Alabama • Birmingham, Alabama • Phoenix, Arizona + 84 more

Conditions: Cellulite
Interventions: Rapid Acoustic Pulse; Device
Lead sponsor: Zeltiq Aesthetics; Industry
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Pleasanton, California

Conditions: Healthy, Traumatic Brain Injury
Interventions: NeuroCatch Platform (NCP); Device
Lead sponsor: Frederick Carrick, PhD, FACCN; Other
Eligibility: 14 Years to 25 Years
Enrollment: 52 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Cape Cañaveral, Florida

Conditions: Fall, Fall Accident, Poly Pharmacy, Adverse Drug Events, Pharmacogenomic Drug Interaction, Pharmacogenomic Testing
Interventions: DNA care pathway; Other
Lead sponsor: Florida Atlantic University; Other
Eligibility: 65 Years to 110 Years
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Delray Beach, Florida

Conditions: Chronic Pain, Pain, Musculoskeletal, Opioid Use, Physical Therapy
Interventions: Mindfulness based practice, Control/Standard Physical Therapy; Behavioral
Lead sponsor: University of Utah; Other
Eligibility: 18 Years to 75 Years
Enrollment: 93 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 2
States / cities: Gainesville, Florida • Salt Lake City, Utah

Conditions: Transcatheter Aortic Valve Replacement
Interventions: Rivaroxaban (Xarelto, BAY59-7939), Acetylsalicylic Acid (ASA), Clopidogrel, Vitamin K antagonist (VKA); Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years and older
Enrollment: 1,653 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 31
States / cities: Los Angeles, California • Washington D.C., District of Columbia • Clearwater, Florida + 27 more

Conditions: Sleep Apnea, Obstructive
Interventions: Belun Ring Pulse Oximeter; Device
Lead sponsor: Belun Technology Company Limited; Other
Eligibility: 18 Years to 90 Years
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Sickle Cell Disease, Thalassemia
Interventions: Etavopivat tablets; Drug
Lead sponsor: Forma Therapeutics, Inc.; Industry
Eligibility: 12 Years to 65 Years
Enrollment: 53 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 14
States / cities: Cerritos, California • Los Angeles, California • Oakland, California + 9 more

Conditions: Breast Cancer, Pretreated Unresectable Locally Advanced or Metastatic HER2+ Breast Cancer
Interventions: Tucatinib, Eribulin, Trastuzumab; Drug
Lead sponsor: Criterium, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 6
States / cities: Aurora, Colorado • Washington D.C., District of Columbia • Albuquerque, New Mexico + 3 more

Conditions: Vascular Ehlers-Danlos Syndrome
Interventions: Enzastaurin, Placebo; Drug
Lead sponsor: Aytu BioPharma, Inc.; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 260 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Englewood, Colorado

Conditions: Hereditary Transthyretin Amyloidosis With Polyneuropthy
Interventions: TEGSEDI; Drug
Lead sponsor: Akcea Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Rosedale, New York

Conditions: Posttraumatic Stress Disorder (PTSD)
Interventions: Prolonged Exposure (PE); Behavioral
Lead sponsor: Research Foundation for Mental Hygiene, Inc.; Other
Eligibility: 18 Years to 60 Years
Enrollment: 95 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: New York, New York

Conditions: Intracranial Pressure
Interventions: Custom Thigh Cuff; Device
Lead sponsor: Saint John's Cancer Institute; Other
Eligibility: 18 Years to 89 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017
U.S. locations: 1
States / cities: Santa Monica, California

Conditions: Recurrent Endometrial Cancer
Interventions: Pembrolizumab, Lenvatinib; Drug
Lead sponsor: University of Miami; Other
Eligibility: 18 Years and older · Female only
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Malignant Neoplasm
Interventions: Telehealth; Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Acute Coronary Syndrome, Chest Pain
Interventions: Not listed
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 21 Years and older
Enrollment: 511 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Search by objective public record fields.

Phase 1 Study of HF-LED-RL in Fitzpatrick Skin Types I to III

Risk of Developing Antibodies to Heparin-PF4 After Heart Surgery

Systematic Quality Improvement With Realtime Event Support

Brief Academic Future Thinking Intervention for College Student Drinkers

Development of an Informed Consent Statement Which Communicates the Risk of Adverse Events Associated With Dry Needling

Hippocampal and Frontoparietal Development and Inference

Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer

Single-agent Cobimetinib for Adults With Histiocytic Disorders

Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.

A Study to Assess the Adverse Events and Effectiveness of Rapid Acoustic Pulse (RAP) Device for the Appearance of Cellulite in Adult Participants

Investigating Event-Related Potentials and Eye-Tracking Measures in Hockey Players

The Geriatric Emergency Department Pharmacologic Harm Prevention Project

Physical Therapy Integrated With Mindfulness for Patients With Chronic Pain and Opioid Treatment

Global Study Comparing a rivAroxaban-based Antithrombotic Strategy to an antipLatelet-based Strategy After Transcatheter aortIc vaLve rEplacement to Optimize Clinical Outcomes

Validation of a Novel Device for Screening Patients With Symptoms of Obstructive Sleep Apnea

A Study of Etavopivat in Patients With Thalassemia or Sickle Cell Disease

Tucatinib+Trastuzumab+Eribulin in HER2+ MBC

Investigate Efficacy, Safety, and Pharmacokinetics of Enzastaurin for the Prevention of Arterial Events in Patients With Vascular Ehlers-Danlos Syndrome.

A Study to Characterize Adverse Events Occurring Within One Day of TEGSEDI Administration to Adult Participants With hATTR-PN

fMRI Predictors of Treatment Response in Posttraumatic Stress Disorder (PTSD)

Mitigating Cephalad Fluid Shifts: A NSBRI Study

Pembrolizumab and Lenvatinib in Mismatch Repair Proficient Recurrent Endometrial Cancer After Progression on or Following First-Line Immunotherapy Maintenance

Telehealth in an Ambulatory Oncology Phase I Clinical Trial Unit

PARA-HEART Pilot Implementation